Kenvue
Price
Price
CHART BY
Historical dividends and forecast
Kenvue has so far distributed $0.41 in 2025. The next dividend will be paid on 28.08.2025
CHART BY
Frequently asked questions
What is Kenvue's market capitalization?
What is Kenvue's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Kenvue?
What are the analyst ratings and target price for Kenvue's stock?
What is Kenvue's revenue over the trailing twelve months?
What is the EBITDA for Kenvue?
What is the free cash flow of Kenvue?
How many employees does Kenvue have, and what sector and industry does it belong to?
What is the free float of Kenvue's shares?
Financials
- Market Cap
- $41.62B
- EPS (TTM)
- $0.548
- Free Float
- 1.92B
- P/E ratio (TTM)
- 39.53
- Revenue (TTM)
- $15.30B
- EBITDA (TTM)
- $3.22B
- Free Cashflow (TTM)
- $1.44B
Pricing
- 1D span
- $21.33$21.92
- 52W span
- $17.68$25.16
Analyst Ratings
The price target is $24.64 and the stock is covered by 20 analysts.
Buy
4
Hold
16
Sell
0
Information
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
- Employees
- 22,000
- Industries
- Household/ Personal Care
- Sector
- Consumer Staples
Identifier
- ISIN
- US49177J1025
- Primary Ticker
- KVUE